Stocks and Investing Stocks and Investing
Fri, November 12, 2021
Thu, November 11, 2021
Wed, November 10, 2021
Tue, November 9, 2021

Gena Wang Maintained (ARCT) at Sell with Decreased Target to $31 on, Nov 9th, 2021


Published on 2024-10-27 18:34:39 - WOPRAI, Gena Wang
  Print publication without navigation


Gena Wang of Barclays, Maintained "Arcturus Therapeutics Holdings Inc." (ARCT) at Sell with Decreased Target from $46 to $31 on, Nov 9th, 2021.

Gena has made no other calls on ARCT in the last 4 months.



There are 5 other peers that have a rating on ARCT. Out of the 5 peers that are also analyzing ARCT, 0 agree with Gena's Rating of Hold.



These are the ratings of the 5 analyists that currently disagree with Gena


  • Yigal Nochomovitz of "Citigroup" Maintained at Strong Buy with Decreased Target to $114 on, Wednesday, August 25th, 2021
  • Steven Seedhouse of "Raymond James" Downgraded from Hold to Sell on, Thursday, August 12th, 2021
  • Madhu Kumar of "Goldman Sachs" Downgraded from Hold to Strong Sell and Held Target at $29 on, Wednesday, August 11th, 2021
  • Brian Cheng of "Cantor Fitzgerald" Maintained at Buy with Increased Target to $85 on, Tuesday, August 10th, 2021
  • Joel Beatty of "Baird" Downgraded from Hold to Sell on, Tuesday, August 10th, 2021